C8-Ceramide (N-Octanoyl-D-erythro-sphingosine) 是一种细胞渗透性的内源性神经酰胺类似物。C8-Ceramide 具有具有抗增殖特性,能作为化疗试剂。C8-Ceramide 能刺激树突状细胞促进 T 细胞对病毒感染的反应。C8-Ceramide 在体外能轻微地诱导 PKC 活化。
C8-Ceramide Chemical Structure
CAS No. : 74713-59-0
规格
价格
是否有货
数量
5 mg
¥2950
In-stock
10 mg
询价
50 mg
询价
* Please select Quantity before adding items.
C8-Ceramide 相关产品
•相关化合物库:
Bioactive Compound Library Plus
Apoptosis Compound Library
Epigenetics Compound Library
Immunology/Inflammation Compound Library
Kinase Inhibitor Library
TGF-beta/Smad Compound Library
Anti-Cancer Compound Library
Autophagy Compound Library
Oxygen Sensing Compound Library
Cytoskeleton Compound Library
Anti-Lung Cancer Compound Library
生物活性
C8-Ceramide (N-Octanoyl-D-erythro-sphingosine) is a cell-permeable analog of naturally occurring ceramides. C8-Ceramide has anti-proliferation properties and acts as a potent chemotherapeutic agent. C8-Ceramide stimulates dendritic cells to promote T cell responses upon virus infections. C8-Ceramide induces slight activation of protein kinase (PKC) in vitro[1][2][3][4].
IC50 & Target[2][4][5]
PKC
apoptosis
autophagy
体外研究 (In Vitro)
C8-ceramide (3 μM; 48 hours) irreversibly reduces tumor-cell proliferation and induces morphological changes[1]. C8-ceramide can induce necrosis-like cell death, but does not induce caspase-dependent cleavage of PARP (biochemical marker of apoptosis) in human cervical tumor cells[1]. C8-ceramide may increase the endogenous ROS level (10-30 µM; 24 hours) by regulating the switch of SOD1 and SOD2, causing the anti-proliferation (10-50 µM; 24 hours), and consequently triggering the apoptosis (10-50 µM; 48 hours) of NSCLC H1299 cells[2].
Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay[1]
Cell Line:
CALO cells, INBL cells, HeLa cells
Concentration:
3 μM
Incubation Time:
48 hours
Result:
Markedly reduced the tumor cell number.
Cell Proliferation Assay[2]
Cell Line:
H1299 cells
Concentration:
10 µM, 20 µM, 30 µM, 40 µM, 50 µM
Incubation Time:
24 hours
Result:
Decreased the rate of cellular proliferation in a dose-dependent manner, with an IC50 of 22.9 µM.
Cell Cycle Analysis[2]
Cell Line:
H1299 cells
Concentration:
10 µM, 20 µM, 30 µM, 40 µM, 50 µM
Incubation Time:
24 hours
Result:
Caused the G1 arrest.
Apoptosis Analysis[2]
Cell Line:
H1299 cells
Concentration:
10 µM, 20 µM, 30 µM
Incubation Time:
24 hours, 48 hours
Result:
Increased the level of cleaved caspase-3.
体内研究 (In Vivo)
C8-ceramide (0.1 mg/kg; intranasal administration) induces more robust CD8+ and CD4+ T cell responses to viral infections in virus infected mice[3].
Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model:
C57BL/6 mice, with lymphocytic choriomeningitis virus infected[3]
Dosage:
0.1 mg/kg
Administration:
Intranasal administration
Result:
Increased the CD8+ T cell response to influenza in the lungs.
分子量
425.69
Formula
C26H51NO3
CAS 号
74713-59-0
中文名称
N-辛酰基-D-神经鞘氨醇
运输条件
Room temperature in continental US; may vary elsewhere.
[1]. Rebeca López-Marure , et al. Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosis. Biochem Biophys Res Commun. 2002 May 10;293(3):1028-36.
[2]. Yuli C. Chang, et al. Exogenous C8-Ceramide Induces Apoptosis by Overproduction of ROS and the Switch of Superoxide Dismutases SOD1 to SOD2 in Human Lung Cancer Cells. Int J Mol Sci. 2018 Oct; 19(10): 3010.
[3]. Curtis J. Pritzl, et al. A ceramide analogue stimulates dendritic cells to promote T cell responses upon virus infections. J Immunol. 2015 May 1; 194(9): 4339-4349.
[4]. H W Huang, et al. Ceramides modulate protein kinase C activity and perturb the structure of Phosphatidylcholine/Phosphatidylserine bilayers. Biophys J. 1999 Sep; 77(3): 1489-1497.
[5]. Lan Weiss, et al. Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy. Hum Mol Genet. 2021 Jan 7;ddaa248.